Genomic Alterations Converge on Lipid Metabolism and ERBB2 in Breast Cancer.
Shantanu Chowdhury, Divya Khanna, Arnab Ghosh, Priyanka Bhadwal et autres
in, ro, gb (code pays fourni par la source)
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Shantanu Chowdhury, Divya Khanna, Arnab Ghosh, Priyanka Bhadwal et autres
in, ro, gb (code pays fourni par la source)
Khusbhoo A. Gandhi, Rohan Chaubal, Elizabeth Talker, Jaya Chitra Aadhi et autres
The original version of this Article contained an error in Figure 5, where one image corresponding to the G1 mice was inadvertently mislabelled as G0 during microscopy image acquisition and subsequent file organization. This mislabelling resulted in the incorrect assignment of a …
in (code pays fourni par la source)
Jinesh Maniar, Pranali Dhas, Pulkit Datt, Prerana Dange et autres
in (code pays fourni par la source)
Mamta Gurav, Omshree Shetty, Shalaka Joshi, Seema Gulia et autres
Invasive micropapillary carcinoma (IMPC) of the breast, a rare and aggressive subtype, represents a unique morphology of reversed polarity with higher metastatic propensity. Due to the limited availability of experimental models, understanding distinct molecular pathways and potential therapeutic targets remains challenging. This …
in (code pays fourni par la source)
Suhail Ahmad, Ashwin Butle, Akshay Karn, Roma Sunder et autres
in (code pays fourni par la source)
Divya Khanna, Arnab Ghosh, Priyanka Bhadwal, Ramakanth Chirravuri-Venkata et autres
Abstract Breast cancer remains the leading cause of cancer-related mortality among women globally, yet South Asian populations are critically underrepresented in genomic studies. Here, we present whole-genome and transcriptome analyses of over 500 treatment-naïve, clinically annotated breast tumors from India, representing the …
in, sa (code pays fourni par la source)
Nilesh Gardi, Rohan Chaubal, Khushboo Gandhi, Anushree Kadam et autres
Background and objectives Genomic studies are essential for identifying mutations that may influence key aspects of breast tumours, such as susceptibility, aggressiveness, and response to treatment. There are deficient molecular and genomic data from Indian breast cancer patients. Methods mRNA from primary …
in (code pays fourni par la source)
Khushboo Gandhi, Rohan Chaubal, Elizabeth Talker, Jaya Chitra Aadhi et autres
Limited success has been achieved in the development of patient-derived xenografts (PDX) models of hormone receptor-positive (HR+), Human Epidermal growth factor Receptor 2-negative (HER2-negative) metastatic breast cancers that are resistant to hormone therapy (HT). We aimed to establish and characterize PDX models …
in (code pays fourni par la source)
Rohan Chaubal, Elizabeth Talker, Jaya Chitra, Rasika Kadam et autres
PURPOSE: We aimed to characterize the genomic landscape of hormone receptor-positive (HR+)/HER2-negative breast cancer in patients with hormone therapy-resistant and -sensitive phenotypes. METHODS: HR+/HER2-negative patients who were disease-free for ≥2 years were considered hormone therapy-sensitive (n = 19), while those who experienced …
in (code pays fourni par la source)
Jyoti Bajpai, Rohan Chaubal, Rajiv Sarin, Venkatesh Kapu et autres
Abstract Background: Pregnancy-associated breast cancer (PABC) encompassing breast cancer diagnosed during pregnancy or one-year post-partum is a rare and challenging entity wherein oncologists need to safeguard maternal oncological and foetal outcomes simultaneously. Little is known about genomic signatures which is worth exploring …
Riddhi Ursekar, Rohan Chaubal, Khushboo Gandhi, Elizabeth Talker et autres
Breast cancer contributes a large fraction to mortality among women diagnosed with cancer. It is important to monitor residual disease and extend the lead time to detect relapse in high-risk patients. Minimally invasive techniques that utilise circulating biomarkers are being explored for …
in (code pays fourni par la source)
Rushikesh Mukhare, Khushboo Gandhi, Aishwarya Raja, Ankita Singh et autres
Organoids represent a significant advancement in disease modeling, demonstrated by their capacity to mimic the physiological/pathological structure and functional characteristics of the native tissue. Recently CRISPR/Cas9 technology has emerged as a powerful tool in combination with organoids for the development of novel …
in (code pays fourni par la source)
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic